Milrinone
SIGMA/M4659 - ≥97% (TLC), powder
Synonym: 1,6-
CAS Number: 78415-72-2
Empirical Formula (Hill Notation): C12H9N3O
Molecular Weight: 211.22
EC Number: 278-903-6
MDL Number: MFCD00133539
Linear Formula: C12H9N3O
Product Type: Chemical
| assay | ≥97% (TLC) |
| color | off-white |
| form | powder |
| InChI | 1S/C12H9N3O/c1-8-11(9-2-4 |
| InChI key | PZRHRDRVRGEVNW-UHFFFAOYSA |
| originator | Sanofi Aventis |
| Quality Level | 200 ![]() |
| SMILES string | CC1=C(C=C(C#N)C(=O)N1)c2c |
| solubility | DMSO: >10 mg/mL |
| H2O: insoluble | |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | Phosphodiesterase type III inhibitor; cAMP-specific, cGMP-inhibitable; potent cardiotonic, positive inotropic vasodilator. |
| Features and Benefits: | This compound is a featured product for Cyclic Nucleotide research. Click here to discover more featured Cyclic Nucleotide products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: | This compound is featured on the Phosphodiesterases page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by Sanofi Aventis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 10 mg in poly bottle |
| Packaging: | 50 mg in glass bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P301 + P330 + P331 + P310 |
| Hazard Codes | T |
| Risk Statements | 23/24/25 |
| Safety Statements | 36/37/39-45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥97% (TLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 41106305 |


